Liang Xiong

Dr. Liang Xiong

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
CCChunwei Cheng
Chunwei Cheng
JHJuan Hua
Juan Hua
LXLiang Xiong
Liang Xiong
Objective: Currently, there is limited evidence regarding the use of direct oral anticoagulants (DOACs) for patients with liver cirrhosis (LC). We performed a meta-analysis to compare the efficacy and safety of DOACs versus warfarin in this population. Methods: We searched PubMed, Cochrane Library, Web of Science, Embase and Scopus databases from inception to August 2024. Clinical studies comparing the use of DOACs with warfarin in cirrhotic patients were included. Hazard ratios (HRs) with 95% CIs were estimated by either fixed or random effects models. Primary efficacy outcomes were ischemic stroke/thromboembolism (IS/TE) and all-cause death, the primary safety outcomes were the bleeding risks. Results: Sixteen studies were included (16 829 individuals). DOACs had similar benefits in preventing IS/TE (HR = 0.87, 95% CI: 0.69-1.10), but DOACs were significantly associated with reduced risk of all-cause death (HR = 0.87, 95% CI: 0.79-0.97). On the other hand, we observed significantly reduced risks of any bleeding (HR = 0.60; 95%CI: 0.37-0.95), major bleeding (HR = 0.72; 95%CI: 0.63-0.82), intracranial hemorrhage (ICH) (HR = 0.47; 95%CI: 0.30-0.73), and gastrointestinal bleeding (GIB) (HR = 0.72, 95% CI: 0.60-0.87) in patients receiving DOACs. Results were consistent in cirrhotic patients with AF. Furthermore, DOACs reduced the incidence of major bleeding (HR = 0.65, 95%CI: 0.55-0.78) and ICH (HR = 0.17, 95%CI: 0.04-0.76) in patients with moderate to severe cirrhosis. Conclusion: Our study demonstrates that DOACs, compared with warfarin, exerted comparable efficacy and better safety and may represent a safer alternative to warfarin in cirrhotic patients.

21 November 2024 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
LXLiang Xiong
Liang Xiong
JHJinzhu Hu
Jinzhu Hu
DWDandan Wang
Dandan Wang
JHJuan Hua
Juan Hua
QCQi CHen
Qi CHen
Ventricular premature contractions (VPC) originating from right ventricular outflow tract is the most common type of ventricular arrhythmias in clinic settings, which can be effectively cured by catheter ablation. Interruption of the inferior vena cava (IVC) is a rare vascular anomaly resulting from aberrant development during embryogenesis. Herein, we reported a very rare case of VPC originating from right ventricular outflow tract (RVOT) with interruption of IVC, which was successfully ablated by transfemoral vein approach.

28 October 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
JXJintao Xie
Jintao Xie
DWDandan Wang
Dandan Wang
JHJuan Hua
Juan Hua
QCQi CHen
Qi CHen
LXLiang Xiong
Liang Xiong

2 April 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
LXLiang Xiong
Liang Xiong
LQLili Qiu
Lili Qiu
XXXiaowen Xie
Xiaowen Xie
DWDandan Wang
Dandan Wang
JHJuan Hua
Juan Hua
QCQi CHen
Qi CHen

9 July 2024 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Open access
PDF file
JHJuan Hua
Juan Hua
ZXZiyi Xiong
Ziyi Xiong
QKQiling Kong
Qiling Kong
DWDandan Wang
Dandan Wang
JLJinwei Liu
Jinwei Liu
LXLiang Xiong
Liang Xiong
Purpose: To evaluate the ventricular electrophysiologic effects of long-term stimulation of the left dorsal branch of thoracic nerve (LDTN) derived from the left stellate ganglion (LSG) in a canine model of chronic myocardial infarction (MI). Methods: Seventeen adult male beagles were randomly divided into three groups: the sham group (sham operated, n = 6), the MI group ( n = 6), and the MI + LDTN group (MI plus LDTN stimulation, n = 5). The canine model of chronic MI was induced by the occlusion of the left anterior descending artery (LADO). The LDTN was separated and intermittently stimulated immediately after LADO for 2 months. The heart rate variability (HRV) analysis, in vivo electrophysiology, the evaluation of LSG function and neural activity, histological staining, and western blotting (WB) assay were performed to evaluate the effect of LDTN stimulation on the heart. Results: The canine MI model was successfully established by LADO, and the LDTN was separated and stimulated immediately after LADO. The HRV analysis showed that LDTN stimulation reversed the increased LF value and LF/HF ratio of the MI group. LDTN stimulation prolonged the shortening ERP and APD90, decreased the dispersion of ERP and APD90, and increased the VFT. Additionally, LDTN stimulation inhibits the LSG function and neural activity. Furthermore, LDTN stimulation suppressed the activation of Wnt/β-catenin signaling, which contributed to the LSG neuronal apoptosis by upregulation of pro-apoptotic Bax and downregulation of anti-apoptotic Bcl-2. Conclusion: LDTN stimulation could attenuate cardiac sympathetic remodeling and improve ventricular electrical remodeling, which may be mediated by suppressing the activated Wnt/β-catenin signaling pathway and then promoting the LSG neuronal apoptosis.

11 November 2024
Verified
Preprint
Open access
HLHao Li
Hao Li
LXLiang Xiong
Liang Xiong
DWDandan Wang
Dandan Wang
JHJuan Hua
Juan Hua
QCQi Chen
Qi Chen
We report a case of a patient with paroxysmal atrial fibrillation associated with left-side accessory pathway treated with pulsed field ablation. The patient successfully achieved long-term control of atrial fibrillation, which provides a new therapeutic option for clinical decision-making.